Skip to main content

Table 5 Correlation between duration of illness and PLT count and between FIB-4 and PLT count in the three treatment groups

From: Impact of different anti-HCV regimens on platelet count during treatment in Egyptian patients

Subgroup Parameter Platelet count decrement
Week 2 Week 4 EOT
Group 1
Triple
Duration of illness Correlation coefficient .076 .117 .109
p value .578 .391 .424
N 56
Group 2
SOF/RBV
Correlation coefficient .063 .071 − .125
p value .649 .608 .364
N 55
Group 3
SIM/SOF
Correlation coefficient .129 .022 − .004
p value .338 .871 .974
N 57 57 55
Group 1
Triple
FIB-4 calculation Correlation coefficient − .267 − .213 − .110
p value .047 .114 .418
N 56
Group 2
SOF/RBV
Correlation coefficient -.486 − .463 − .105
p value < 0.001 < 0.001 .445
N 55
Group 3
SIM/SOF
Correlation coefficient − .243 − .494 − .151
p value .069 < 0.001 .270
N 57 57 55